Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antiplatelet therapy after lower-extremity peripheral transluminal angioplasty
NL-OMON28759Not yet recruiting
- Sponsor
- St. Antonius Ziekenhuis
- Start
- Jul 2016
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Randomised trial in arteriosclerosis obliterans comparing Aspirin, Aspirin + clopidogrel and Ticagrelor (3 arms). Primary endpoint: Composite cardiovascular and limb event endpoint at 1 year. Planned start Jul 2016; status: not yet recruiting.
02
Drugs
aspirinclopidogrelticagrelor
03
Conditions
arteriosclerosis obliterans
Beyond the preview
Go deeper on NL-OMON28759.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON28759.